“The Lines Are Not Blurred”: Attorney Claim Handlers Are Not Protected by Attorney-Client Privilege
Time 4 Minute Read

A Michigan federal court in Wolverine World Wide Inc. v. The American Insurance Co. et al., No. 1:19-cv-00010 (W.D. Mich.), recently confirmed what should go without saying – a claim handler is a claim handler, even if they may also be a lawyer.  Recognizing that it’s the nature of the work that drives the analysis, the court ordered an in-house Travelers’ attorney to sit for a deposition in a PFAS coverage suit because the attorney was performing ordinary claim-handling activity.  In rejecting the insurer’s arguments, the court reiterated that “an insurer cannot create a ‘shroud of secrecy’ by simply designating an attorney to conduct an otherwise ordinary claim investigation.”

In 2018, Wolverine World Wide Inc., a footwear company, filed a lawsuit against its insurers alleging that the insurers failed to provide coverage for hundreds of PFAS-related lawsuits including tort actions, government suits, and class actions. Travelers is one of three insurance companies that remain in the litigation.

Wolverine sought to depose Michael Ungaro, Travelers’ in-house counsel. Travelers objected to the deposition and refused to present Mr. Ungaro, asserting his status as in-house counsel who “has been intimately involved in Travelers’ defense of this declaratory judgment action” by providing legal advice and overseeing the anticipated and actual coverage action. 

Wolverine disagreed, arguing that Mr. Ungaro should be ordered to testify because (1) he was engaged in the ordinary course of Travelers business of claims handling, including the investigation, handling, analysis, and evaluation of Wolverine’s claim; (2) the court previously ruled that Travelers waived privilege as a sanction for failing to produce its claims notes, files, related documents and communications; and (3) the Eighth Circuit’s Shelton test, which limits those circumstances in which opposing counsel must submit to a deposition, did not apply.[1]

The court granted Wolverines’ motion to compel the deposition testimony of Mr. Ungaro.

The Court’s Analysis

In granting Wolverines’ motion, the court found that Ungaro was performing a business function and acting as a claims handler, regardless of his title. The court reiterated a prior ruling in the instant case where it held that communications by attorneys, not acting as attorneys, but rather acting as insurance claims investigators, are not protected by the attorney-client privilege.

In making its determination, the court considered that Ungaro was actively involved in requesting information concerning Wolverine’s operations, and attended an in-person meeting to discuss Travelers’ claim investigation, handling and evaluation.

The court found that the lines were “not blurred” between Ungaro being the primary claim handler and being the attorney providing legal advice to the primary claim handler. Rather, there was no evidence that Ungaro was discussing potential coverage disputes in anticipation of litigation as in-house counsel and instead, indicated that he was a claims handler.

The court also held that the Eighth Circuit’s three-part Shelton test designed to limit the circumstances that opposing counsel must submit to a deposition did not apply. Under the test, the proponent of the deposition must demonstrate that: (1) there are no other means available to obtain the information other than to depose opposing counsel; (2) the information sought is relevant and non-privileged; and (3) the information is crucial to the preparation of the case.

At the outset, the court held that Ungaro was not opposing counsel, and on that basis alone, the Shelton test did not apply.  But, even if it did, the court found that Wolverine satisfied all three prongs because (1) Ungaro had knowledge beyond that of any other witness; (2) the information regarding Travelers’ claims investigation, notes, guidelines, and claim evaluation was both relevant and critical to Wolverines’ case; and (3) the attorney-client privilege did not extend to Ungaro.

Takeaways

The Wolverine decision reinforces that insurers may not shield claim activity and claim file materials under the guise of the attorney-client privilege simply because a claim handler may also be an attorney.  Rather, it is the function of that individual that matters.  Where insurers use attorneys to conduct ordinary claim functions, discovery from those individuals should be expected and freely provided.

Experienced coverage counsel can help policyholders to recognize when in-house attorneys are, in fact, functioning in a claim-handling capacity and thus subject to the ordinary rules of discovery.


[1] Shelton v. American Motors Corp., 805 F.2d 1323 (8th Cir. 1987).

  • Partner

    Mike is a Legal 500 and Chambers USA-ranked lawyer with more than 25 years of experience litigating insurance disputes and advising clients on insurance coverage matters.

    Mike Levine is a partner in the firm’s Washington, DC ...

  • Associate

    Torrye advises policyholders in complex insurance coverage matters. As a member of the firm’s nationwide insurance coverage team, Torrye represents commercial policyholders in a wide range of matters, including property and ...

You May Also Be Interested In

Time 6 Minute Read

In the case The Estate of Gene B. Lokken v. UnitedHealth Group, Inc., No. 23-CV-3514 (JRT/SGE) (D. Minn.), the plaintiffs alleged that the defendant insurer had denied claims using an artificial intelligence program without human review. They sought discovery into the insurer’s use of AI. When the insurer refused, they moved to compel and the Minnesota federal court granted the motion. Although this case deals with health insurance, its principles are widely applicable to all other types of insurance. Insurers are increasingly using AI to evaluate or even deny claims without human review. They also use it to challenge policyholders’ expenses as too high. Courts are beginning to allow discovery into how AI was used in the claim process. Accordingly, requests for AI chat files, use policies, and documents concerning oversight of AI should now be a standard part of every policyholder’s discovery requests in coverage litigation.

Time 4 Minute Read

On February 6, 2026, the US Environmental Protection Agency issued a press release highlighting significant actions addressing per- and polyfluoroalkyl substances (PFAS) taken during the first year of the new administration and signaling continued expansion of efforts affecting regulated entities. The announcement reiterates EPA’s continued commitment to making PFAS a top priority across its programs. The release also summarizes EPA’s PFAS testing approach and methods for identifying and measuring PFAS in various environmental media, the results of which will guide the agency’s future actions. Overall, EPA expects to expand research and testing, increase community engagement, and strengthen enforcement actions to address PFAS contamination.

Time 6 Minute Read

Chemical manufacturers, product makers, and product retailers are gearing up for new state-level restrictions on products sold in stores and online that contain per- and-polyfluoroalkyl substances (PFAS). A total of 18 states have PFAS product restrictions ranging from bans to reporting to labeling requirements. The laws target primarily food packaging, cosmetics, cookware, and textiles, but some states have expansive laws that include all types of products. Each year for the past four years, approximately 200 PFAS-related bills are introduced in state legislatures, and we expect this trend to continue, potentially adding to the growing patchwork of PFAS restrictions.

Time 5 Minute Read

On November 10, 2025, the US Environmental Protection Agency (EPA) issued a pre-publication copy of its proposed rule to significantly reduce the scope of PFAS reporting under Section 8(a)(7) of the Toxic Substances Control Act (TSCA). Significantly, EPA’s proposal would exempt imported articles from reporting. Once the proposed rule is published in the Federal Register, it will be subject to a 45-day comment period.

Search

Subscribe Arrow

Recent Posts

Categories

Tags

Authors

Archives

Jump to Page